Blockade of the Sigma-1 Receptor Relieves Cognitive and Emotional Impairments Associated to Chronic Osteoarthritis Pain
Osteoarthritis is the most common musculoskeletal disease worldwide, often characterized by degradation of the articular cartilage, chronic joint pain and disability. Cognitive dysfunction, anxiety and depression are common comorbidities that impact the quality of life of these patients. In this stu...
Main Authors: | Mireia Carcolé, Daniel Zamanillo, Manuel Merlos, Begoña Fernández-Pastor, David Cabañero, Rafael Maldonado |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00468/full |
Similar Items
-
Sigma-1 Receptor-Modulated Neuroinflammation in Neurological Diseases
by: Jia Jia, et al.
Published: (2018-09-01) -
Supraspinal and Peripheral, but Not Intrathecal, σ1R Blockade by S1RA Enhances Morphine Antinociception
by: Alba Vidal-Torres, et al.
Published: (2019-04-01) -
The role of ozone therapy in maintaining the articular function and in relieving the pain for patients with knee osteoarthritis
by: Camelia Ciobotaru, et al.
Published: (2014-02-01) -
The contribution of spinal glial cells to chronic pain behaviour in the monosodium iodoacetate model of osteoarthritic pain
by: Sagar Devi, et al.
Published: (2011-11-01) -
CCL17 blockade as a therapy for osteoarthritis pain and disease
by: Ming-Chin Lee, et al.
Published: (2018-04-01)